HP-NAP of Helicobacter pylori: The Power of the Immunomodulation

24Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

The miniferritin HP-NAP of Helicobacter pylori was originally described as a neutrophil-activating protein because of the capacity to activate neutrophils to generate oxygen radicals and adhere to endothelia. Currently, the main feature for which HP-NAP is known is the ability to promote Th1 responses and revert the immune suppressive profile of macrophages. In this review, we discuss the immune modulating properties of the protein regarding the H. pylori infection and the evidence that support the potential clinical application of HP-NAP in allergy and cancer immunotherapy.

Cite

CITATION STYLE

APA

Codolo, G., Coletta, S., D’Elios, M. M., & de Bernard, M. (2022, June 29). HP-NAP of Helicobacter pylori: The Power of the Immunomodulation. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2022.944139

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free